CBN

PAX Debuts Novel, Science-Backed Product for Better Sleep

Retrieved on: 
Tuesday, November 7, 2023
Women, Cannabis, Men, Specialty, Alternative Medicine, General Health, Consumer, Health, Retail, Natural Resources, High Times, FDA, Pax Labs, Obesity, TIME, PAX, Terpene, Diabetes, Doctor of Philosophy, CBN, Research, ERA, Dementia, Multimedia, National Health, All rights reserved, Disease, Medicine, Risk, Somnolence, GQ, Cannabinol, Accident, Culture, Depression, Cannabinoid, Anxiety, National Health Interview Survey, Insomnia, Diagnosis, Obstructive sleep apnea, Pharmaceutical industry, Video game, Sleep

PAX , a leading global cannabis brand, today announced the launch of Sleep by PAX, a first-of-its-kind, science-driven inhalable pod formula for the PAX Era platform.

Key Points: 
  • PAX , a leading global cannabis brand, today announced the launch of Sleep by PAX, a first-of-its-kind, science-driven inhalable pod formula for the PAX Era platform.
  • Sleep by PAX leverages a unique blend of cannabinoids and terpenes, developed to help consumers get to sleep faster, improve their sleep quality and ultimately get more restorative sleep.
  • Many Americans are sleep-deprived, which is having a significant impact on health and wellbeing,” said Brian Witlin, VP of Product Development at PAX.
  • Sleep by PAX is now available in a 1G pod format in Colorado starting at $40 and in Massachusetts starting at $60.

NexGen Sciences and Polaris Cannabis Announce Strategic Partnership to Revolutionize Cannabinoid and Cannabis Industry

Retrieved on: 
Wednesday, November 1, 2023
Knowledge, Delta, Sale, CSO, CBD, Terpene, Nano, CBN, Athlete, Head cheese, Partnership, Cannabinoid, Pain management, Drug, Cannabis, Polaris

COSTA MESA, Calif., Nov. 1, 2023 /PRNewswire/ -- NexGen Sciences , a leading innovator in nano-cannabinoid formulations, and Polaris Cannabis , a prominent player in the cannabis industry, announce that they have formed a strategic partnership, by which Polaris will have the exclusive rights to use NexGen Sciences' proprietary technology in products for sale in California, the world's largest cannabis market.

Key Points: 
  • COSTA MESA, Calif., Nov. 1, 2023 /PRNewswire/ -- NexGen Sciences , a leading innovator in nano-cannabinoid formulations, and Polaris Cannabis , a prominent player in the cannabis industry, announce that they have formed a strategic partnership, by which Polaris will have the exclusive rights to use NexGen Sciences' proprietary technology in products for sale in California, the world's largest cannabis market.
  • NexGen Sciences, known for its proprietary Water Soluble Nano-Technology, has established itself as a premier producer of cannabinoid formulas.
  • "We are excited to join forces with Polaris Cannabis," said Richard Staack, President/CSO, NexGen Sciences.
  • "NexGen Sciences' cutting-edge formulations align perfectly with our commitment to produce high-quality, medicinal cannabis products," added Peter Ishak, CSO, Polaris Cannabis.

Hemp, Inc. Profiled as One of the Leading, Innovative Companies in Recent Industrial Hemp Market Report

Retrieved on: 
Tuesday, October 24, 2023
Paper, Convention (norm), Textile, Water, Health, Food, CBGA, Clay, OTC, Coffee, Paint, Absorption, CBN, Cellulose, CBG, Environment, Rest, Plant, CBDA, Pathfinder, Cannabinoid, LCM, Clothing, Fiber crop, Drug, CBD, Hemp

LAS VEGAS, NV, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -  A recent report by 360iResearch cited Hemp, Inc. (OTC PINK: HEMP) as one of the leading and innovative companies in the industrial hemp market, a market it says will be worth $81.54 billion by 2030.

Key Points: 
  • LAS VEGAS, NV, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -  A recent report by 360iResearch cited Hemp, Inc. (OTC PINK: HEMP) as one of the leading and innovative companies in the industrial hemp market, a market it says will be worth $81.54 billion by 2030.
  • The exclusive report, Industrial Hemp Market by Type (Hemp Fiber, Hemp Flower), Source (Conventional, Organic), Application – Global Forecast 2023 - 2030 , categorizes the industrial hemp market into sub-markets in order to forecast the revenues and trends in each.
  • With over 14 years of experience in hemp cultivation, hemp farming, hemp processing, and educating on the benefits of hemp, Hemp, Inc. plays a pivotal role in the industrial hemp industry.
  • These factors are influencing the hemp market and creating exponential growth opportunities for Hemp, Inc. and other industry businesses in the hemp market.

Rubicon Organics™ Launches Wildflower™ Edibles Crafted with CBD, CBN & CBG

Retrieved on: 
Tuesday, October 24, 2023
Sweet Dreams, CBN, Rubicon, CBG, Cannabinoid, Blood orange, Beer, Wine, Tea, Cherry, CBD

VANCOUVER, British Columbia, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Rubicon Organics™ Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today announces the launch of Wildflower™ brand edibles crafted with minor cannabinoids including CBD, CBN and CBG.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Rubicon Organics™ Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today announces the launch of Wildflower™ brand edibles crafted with minor cannabinoids including CBD, CBN and CBG.
  • “I am excited to expand the Wildflower™ brand into a new product category with our launch of minor cannabinoid edibles,” said Melanie Ramsey, Chief Commercial Officer.
  • “At Rubicon Organics™ we strive to deliver innovative and premium products and these edibles are a significant step to expanding our Wildflower™ product line-up to offer a range of high-quality, natural gummies.
  • Daily Bliss Lemon Ginger CBG + CBD Gummies: naturally sweetened with real fruit purée, vegan, gluten free with no added sugar, or colours.

Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids

Retrieved on: 
Wednesday, October 11, 2023
Biotechnology, Natural Resources, Pharmaceutical, Alternative Medicine, General Health, Health, Cannabis, Other Health, C13, Cannabis Act, Cannabidivarin, THC, Drug reference standard, Cannabinoid, Health Canada, API, Seed, FDA, CBN, CGMP, Tetrahydrocannabivarin, CBD, Standard, Fine chemical

Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023.

Key Points: 
  • Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023.
  • With the new Cannabis Drug License, Eurofins CDMO Alphora can supply cGMP grade Cannabinoids for use in Drug therapies.
  • Eurofins CDMO Alphora operations are approved by Health Canada and the FDA and have manufactured clinical stage and commercial-stage APIs since 2008.
  • Eurofins CDMO Alphora Inc. has since developed scalable processes for several naturally occurring phytocannabinoids including CBD, CBDv, THC, THCv, and CBN.

Global Grinding Machines Market Expected to Grow at 5.2% CAGR: Surface and Cylindrical Grinding Machines Lead the Way - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 4, 2023
Other Manufacturing, Technology, Steel, Engineering, Other Technology, Automotive Manufacturing, Aerospace, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Diamond, Aircraft, Housing, Business, CBN, 2nd Aircraft Delivery Group, Airbus, Growth, Automotive industry, New Normal

Global PMI Index Points for the Years 2018, 2019 & 2020

Key Points: 
  • Global PMI Index Points for the Years 2018, 2019 & 2020
    Stable Demand for New Generation Machine Tools Opens a Parallel Opportunity for the Growth of Grinding Machines: Global Market for Machine Tools (In US$ Million) for Years 2023, 2025 and 2027
    Growing Preference for Super-Abrasives Wheels, CBN and Diamond
    Commercial Aircraft Orders & Deliveries for Airbus for the Year 2022 Vs. 2021 (In Units)
    New Route Expansion Signals a Good Return to Business & a Strong Business Case for New Aircraft Orders & Deliveries: Number of New Aircraft Demanded (In Units) as a Result of New Air Route Expansion by 2041
    United States Housing Units Starts: 2015-2021 (Housing Units in Thousands)
    World Automobile Production in Million Units: 2008-2022
    Pandemic Impact on the Automotive Industry & What's the New Normal?

FloraWorks Appoints Cannabis Scientist Dr. Mike McCormick as VP of Strategy

Retrieved on: 
Wednesday, October 4, 2023
National academy, Therapy, Doctor of Philosophy, ARCH Venture Partners, Cannabinoid, IP, Science, Sleep, Chemistry, CBN, Cannabinol, Publication, M.I.T, Scripps Research, Entrepreneurship, Health, Safety, Pharmaceutical industry, Nature, Biochemistry

Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc. , a leading cannabinoid therapeutics company, announced the appointment of Dr. Mike McCormick as VP of Strategy.

Key Points: 
  • Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc. , a leading cannabinoid therapeutics company, announced the appointment of Dr. Mike McCormick as VP of Strategy.
  • A science and intellectual property consultant for FloraWorks since 2022, Dr. McCormick brings extensive expertise in cannabinoid biochemistry, innovation, and IP protection.
  • Within the cannabis industry, Dr. McCormick focuses on industrial and academic technology transfer, and the development of next-generation therapeutics, consumer products, scientific methods, and educational content.
  • "We are thrilled to welcome Dr. McCormick to the leadership team during this momentous time for our company," said Alleh Lindquist , CEO and Co-Founder of FloraWorks.

Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being

Retrieved on: 
Tuesday, October 3, 2023
Volunteering, GABA, Theanine, Doctor of Pharmacy, Melatonin, University, Doctor, Anxiety, Sleep, Clinical trial, Public, Cannabinoid, Research, Harvard University, Maryland School, MCID, CBN, Harvard T.H. Chan School of Public Health, Public health, MD, Polypharmacology, University of Maryland School of Medicine, CBD, FACS, Faculty, Entrepreneurship, UCLA, THC, Pharmaceutical industry, Dietary supplement, Medicinal plants, Nutrient

Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared to placebo.

Key Points: 
  • Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared to placebo.
  • Results showed the formulation enhanced sleep onset, and supported restful and healthy sleep.
  • Furthermore, the product led to significant improvements in feelings of anxiety, stress, and well-being compared to placebo.
  • This study was one of history’s largest double-blind randomized placebo controlled trials to demonstrate effectiveness of a non-melatonin supplement for improving sleep.

Innovations and Automation Fuel Demand for Grinding Machines: Key Players Include Amada Machinery, Danobat, and Makino

Retrieved on: 
Friday, September 29, 2023
Diamond, Aircraft, Real, Machine, Housing, Introduction, Business, CBN, Food delivery, Airbus, Growth, Automotive industry, Interest, New Normal, Tourism

The Indispensable Role of Grinding Machines in Industrial Applications: Foundation for Market Growth

Key Points: 
  • The Indispensable Role of Grinding Machines in Industrial Applications: Foundation for Market Growth
    From Pandemic to War & Inflation: "Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions
    Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue
    Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
    Global Grinding Machines Market Exhibits Robust Growth, driven by Introduction of Innovative Technologies
    Global PMI Index Points for the Years 2018, 2019 & 2020
    Stable Demand for New Generation Machine Tools Opens a Parallel Opportunity for the Growth of Grinding Machines: Global Market for Machine Tools (In US$ Million) for Years 2023, 2025 and 2027
    Growing Preference for Super-Abrasives Wheels, CBN and Diamond
    Commercial Aircraft Orders & Deliveries for Airbus for the Year 2022 Vs. 2021 (In Units)
    New Route Expansion Signals a Good Return to Business & a Strong Business Case for New Aircraft Orders & Deliveries: Number of New Aircraft Demanded (In Units) as a Result of New Air Route Expansion by 2041
    United States Housing Units Starts: 2015-2021 (Housing Units in Thousands)
    World Automobile Production in Million Units: 2008-2022
    Pandemic Impact on the Automotive Industry & What's the New Normal?

Hemp, Inc. Reports: Growing Legalization of Industrial Hemp Driving Global Demand for Hemp

Retrieved on: 
Thursday, September 28, 2023
CBDA, Valine, Food, Diet, Methionine, Lysine, Seed, Paint, Leucine, Threonine, Clothing, Cannabinoid, Absorption, Dicarboxylic acid, CBG, Phenylalanine, CBN, Tryptophan, Plant, Investment, OTC, Histidine, Coffee, Paper, Health, Textile, CBGA, Isoleucine, Rest, Dietary supplement, Hemp, CBD

LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.

Key Points: 
  • LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.
  • The recent release of a comprehensive research report, Global Industrial Hemp Market (2023-2031) , says the global industrial hemp market is forecast to grow to $134.6 billion by 2030.
  • As one of the most rapidly growing plants on the planet, hemp is used to make a variety of products.
  • With the “growing legalization of industrial hemp farming around the world, the demand for industrial hemp has been exponential.